Stereotactic Intracerebral Injection of IPSC-DAPs in Patients with Parkinson's Disease
Stereotactic Intracerebral Injection of IPSC-DAPs in Patients with Parkinson's Disease
Not yet recruiting · NCT06821529 · Registry updated 2025-02-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Stereotactic Intracerebral Injection of IPSC-DAPs in Patients with Parkinson's Disease | Parkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathy | Not yet recruiting | Phase 1 | 2025-02-12 | NCT06821529 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| iCamuno Biotherapeutics Ltd. | 2 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 561 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The Second Affiliated Hospital Zhejiang University School of Medicine | Hangzhou | China | 33 |